| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ffd5528fd07384d7b07ab484ed5b143 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 |
| filingDate |
2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beede627129e14df02d065af3061c7c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c690f87e637b7da3a64d48016f8414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51a1321bb88f68dcf36942264bbcbc6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6e1de691378c2234774bb63869ea4a9 |
| publicationDate |
2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2720245-C2 |
| titleOfInvention |
Methods of treating epstein-barr associated lymphoproliferative diseases with the help of t-cell therapy |
| abstract |
FIELD: medicine; oncology.SUBSTANCE: present invention concerns treating Epstein—Barr virus-associated lymphoproliferative disease (EBV-LPD) associated with B-cells. That is ensured by introducing a population of allogenic T-cells containing EBV-specific T-cells limited by a human leukocyte antigen (HLA) allele identical to EBV-LPD cells.EFFECT: invention provides successful treatment of said disease, including in patients resistant to previous combined chemo-, radiation therapy, as well as anti-CD20 monoclonal antibody therapy.69 cl, 1 ex, 1 tbl |
| priorityDate |
2015-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |